Management of the ear, nose, and throat manifestations of Wegener granulomatosis: An otorhinolaryngologist's perspective

Current Opinion in Rheumatology

Volumn 13, Issue 1, 2001, Pages 3-11

  Rasmussen, Niels ^a  

^a Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; COTRIMOXAZOLE; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ANTIBIOTIC THERAPY; ARTICLE; BIOPSY; CLINICAL FEATURE; DIAGNOSTIC TEST; EAR NOSE THROAT DISEASE; ENDOSCOPY; HUMAN; IMAGE ANALYSIS; IMMUNOCOMPETENCE; INFECTION; LARYNX DISORDER; MOUTH DISEASE; OTORHINOLARYNGOLOGY; PARANASAL SINUS; PRIORITY JOURNAL; SALIVARY GLAND DISEASE; STAPHYLOCOCCUS AUREUS; SUBGLOTTIC STENOSIS; SUPERINFECTION; TRACHEA DISEASE; WEGENER GRANULOMATOSIS;

EAR DISEASES; HUMANS; LARYNGEAL DISEASES; MOUTH DISEASES; NASAL MUCOSA; NOSE DISEASES; PARANASAL SINUS DISEASES; SALIVARY GLAND DISEASES; STAPHYLOCOCCAL INFECTIONS; TRACHEAL DISEASES; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; VASCULITIS; WEGENER GRANULOMATOSIS;

EID: 0035159739     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002281-200101000-00002     Document Type: Article

References (55)

1. An interdisciplinary approach to the care of patients with Wegener's granulomatosis: Long-term outcome in 155 patients
2. Über eine eigenartige rhinogene granulomatose mit besonderer beteiligung des arteriensystems und der nieren
3. Nomenclature of systemic vasculitides. Proposal of an international consensus conference
4. Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener granulomatosis
5. Staphylococcal acid phosphatase binds to endothelial cells via charge interaction; a pathogenic role in Wegener's granulomatosis?
6. Autoimmunity in Wegener's granulomatosis
7. Antineutrophil cytoplasmic antibodies
8. Wegener's granulomatosis: Prospective clinical and therapeutic experience with 85 patients for 21 years
9. European therapeutic trials in ANCA-associated systemic vasculitis: Disease scoring, consensus regimens and proposed clinical trials
10. Wegener's granulomatosis - A review of diagnosis and treatment in 53 subjects
11. Head and neck involvement in Wegener's granulomatosis
12. Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis
13. Clinical manifestations of Wegener's granulomatosis
14. Ear, nose and throat manifestations in c-ANCA positive vasculitides
15. Nasal manifestations of Wegener's granulomatosis
16. Nasal manifestations of rheumatic diseases
17. CT of the paranasal sinuses and orbits in patients with Wegener's granulomatosis
18. MRI of the nasal cavity, the paranasal sinuses and orbits in Wegener's granulomatosis
19. Reconstruction of Wegener's nasal deformity using bilateral facial artery musculomucosal flaps
20. Bilateral nasolacrimal duct obstruction managed with endoscopic techniques
21. Lacrimal drainage surgery in Wegener's granulomatosis
22. Otologic manifestations of Wegener's granulomatosis
23. Ear disease in patients with Wegener's granulomatosis
24. Wegener's granulomatosis presenting as mastoiditis
25. Immune-mediated inner ear disease
26. Otologic Wegener's granulomatosis with facial nerve palsy
27. Neurologic involvement in Wegener's granulomatosis: An Analysis of 324 consecutive patients at the Mayo Clinic
28. Wegener's granulomatosis presenting with bulbar palsy and bilateral jugular vein compression
29. "Strawberry" gingival hyperplasia: A pathognomonic mucocutaneous finding in Wegener granulomatosis
30. Oral features of Wegener's granulomatosis
31. More than a mouth ulcer: Oral ulcer due to Wegener's granulomatosis
32. Salivary gland involvement in Wegener's granulomatosis
33. Wegener's granulomatosis, acute laryngotracheal obstruction and death in a 17 year old female: Case report and review of the literature
34. Wegener's granulomatosis of the subglottis and the upper portion of the trachea
35. The management of subglottic stenosis in patients with Wegener's granulomatosis
36. Wegener granulomatosis in children and adolescents: Clinical presentation and outcome
37. Subglottic stenosis in Wegener's granulomatosis: Development during cyclophosphamide treatment with response to carbon dioxide laser therapy
38. Management of the subglottic stenosis in the adult
39. Subglottic stenosis complicating Wegener's granulomatosis: Surgical repair as a viable treatment option
40. Stenting therapy for stenosing airway diseases
41. Deformation and migration of Palmaz stents after placement in the tracheobronchial tree
42. EC/BCR Study Group on ANCA Assay Standardization: Use and abuse of ANCA testing
43. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis
44. Histopathological findings in biopsies from patients with Wegener's granulomatosis
45. Diagnostic usefulness of nasal biopsy in Wegener's granulomatosis
46. Wegener's granulomatosis of the head and neck
47. Microscopic polyangitis (microscopic polyarteritis) with late emergence of generalised Wegener's granulomatosis
48. Patients hospitalized because of small vessel vasculitides with renal involvement in the period 1975-95: Organ involvement, anti-neutrophil cytoplasmic antibodies patterns, seasonal attack rates and fluctuation of annual frequencies
49. Somatostatin analogue scintigraphy in granulomatous diseases
50. Prevention of relapses in Wegener's granulomatosis by treatment based on antineutrophil cytoplasmic antibody titre
51. CRP levels in autoimmune disease can be specified by measurement of procalcitonin
52. Meningeal involvement in Wegener granulomatosis
53. Wegener's granulomatosis: Observations on treatment with antimicrobial agents
54. Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis
55. Molecular approaches for identification of infectious agents in Wegener's granulomatosis and other vasculitides